v3.22.2
Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development $ 15,164 $ 10,902 $ 31,453 $ 22,520
Research and development - licenses acquired   1,000 0 1,000
General and administrative 3,077 2,538 6,426 6,007
Total operating expenses 18,241 14,440 37,879 29,527
Loss from operations (18,241) (14,440) (37,879) (29,527)
Other income (expense)        
Interest income 77 85 150 219
Interest expense (935) (4) (1,165) (8)
Total other income (expense) (858) 81 (1,015) 211
Net Loss $ (19,099) $ (14,359) $ (38,894) $ (29,316)
Net loss per common share outstanding, basic $ (0.19) $ (0.16) $ (0.39) $ (0.35)
Net loss per common share outstanding, diluted $ (0.19) $ (0.16) $ (0.39) $ (0.35)
Weighted average number of common shares outstanding, basic 102,947,158 87,561,764 100,444,938 84,033,508
Weighted average number of common shares outstanding, diluted 102,947,158 87,561,764 100,444,938 84,033,508

Source